Acute ischaemic stroke: Revascularizing therapy

Journal of Neurology

Volumn 245, Issue 9, 1998, Pages 567-572

  Spranger, Matthias ^a   Steiner, Thorsten ^a   Schwab, Stefan ^a   Hacke, Werner ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cerebral ischaemia; Recombinant tissue plasminogen activator; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE; DUTEPLASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DEATH; FIBRINOLYTIC THERAPY; HUMAN; INFARCTION; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; NEUROLOGIC DISEASE; PATIENT SELECTION; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

CEREBRAL REVASCULARIZATION; FIBRINOLYTIC AGENTS; HUMANS; ISCHEMIC ATTACK, TRANSIENT; RANDOMIZED CONTROLLED TRIALS; RECOMBINANT PROTEINS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0031717016     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050247     Document Type: Article

References (31)

1. Adams HP Jr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg, Thies M (1996) Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 94:1167-1174
2. Adams HP Jr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg, Thies M (1996) Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute stroke. Stroke 27:1711-1718
3. Brandt T, Kummer R von, Müller-Küppers M, Hacke W (1996) Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 27:875-881
4. Brott TG, Haley EC Jr, Levy DE, et al (1992) Urgent therapy for stroke I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 23:632-640
5. Candelise L, Aritzu E, Ciccone A, Ricci S, Wardlaw J (1995) Randomised controlled trial of streptokinase in severe acute ischaemic stroke. Lancet 345: 1509-1514
6. Donnan GA, Hommel M, Davis SM, McNeill JJ (1995) Streptokinase in acute ischaemic stroke. Lancet 345:56
7. Donnan GA, Davis SM, Chambers BR, Gates PC, Hankey GJ, McNeil JJ, Rosen D, Stewart-Wynne EG. Tuck RR (1996) Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. JAMA 276:961-966
8. Hacke W, Zeumer H, Ferbert A, Brückmann H, Zoppo GJ del (1988) Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 19:1216-1222
9. Hacke W, Kaste M, Fieschi C, et al (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017-1025
10. Haley EC Jr, Levy DE, Brott TG, et al (1992) Urgent therapy for stroke II. Pilot study of tissue plasminogen activator administered within 91-180 minutes from onset. Stroke 23:641-645
11. Hommel M, Cornu C, Boutitie F, Boissel JP (1996) Thrombolytic therapy with streptokinase in acute ischemic stroke. The Multicenter Acute Stroke Trial-Europe Study Group. N Engl J Med 335:145-150
12. Jansen O, Kummer R von, Forsting M, Hacke W, Sartor K (1995) Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. AJNR Am J Neuroradiol 16: 1977-1986
13. Kaste M, Overgaard K, Zoppo G del, Mummer R von, Orgogozo J-M, Wahlgreen N-G, Bluhmkie E, Mau J, for the ECASS Study Group (1996) Who benefits and who suffers from i.v. recombinant tissue plasminogen activator. Stroke 27:164
14. Kummer R von, Hacke W (1992) Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 23:646-652
15. Kummer R von, Forsting M, Rieke K, Hacke W, Sartor K (1993) Recanalization, infarct volume, cerebral hemorrhage, and clinical outcome after intravenous tissue plasminogen activator and heparin in acute carotid territory stroke. In: Zoppo GJ del, Mori E, Hacke W (eds) Thrombolytic therapy in acute ischemic stroke II. Springer, Berlin Heidelberg New York, pp 53-58
16. Kummer R von, Holle R, Rosin L, Forsting M, Hacke W (1995) Does arterial recanalization improve outcome in carotid territory stroke? Stroke 26: 581-517
17. Levy DE, Brott TG, Haley EC Jr, et al (1994) Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 25: 291-297
18. Mori E, Tabuchi M, Yoshida T, Yamadori A (1988) Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 19: 802-812
19. Mori E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Ohsumi Y, Kitano K, Tsutsumi A, Yamadori A (1992) Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 42: 976-982
20. Multicenter Acute Stroke Trial - Europe Study Group (1996) Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med 335: 145-150
21. Multicenter Acute Stroke Trial - Italy (MAST-I) Group (1995) Randomised controlled trial of strepokinase, aspirin, and combination of both in treatment of acute stroke. Lancet 346: 1509-1514
22. Ringelstein EB, Biniek R, Weiller C, Ammeling B, Nolte PN, Thron A (1992) Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology 42: 289-298
23. Steiner T, Bluhmki E, Kaste M, Toni D, Trouillas P, Kummer R von, Hacke W, for the ECASS Study Group (1998) The ECASS 3h cohort: secondary analysis of ECASS-data by time stratification. Cerebrovasc Dis (in press). Volume number + page not yet available
24. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581-1587
25. The NINDS t-PA Stroke Study Group (1997) Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA stroke trial. Stroke 28: 2119-2125
26. Yamaguchi T (1993) Intravenous tissue plasminogen activator in acute thromboembolic stroke: a placebo-controlled, double blind trial. In: Zoppo GJ del, Mori E, Hacke W (eds) Thrombolytic therapy in acute ischemic stroke II. Springer, Berlin Heidelberg New York, pp 59-65
27. Yamaguchi T, Hayakawa T, Kikuchi H, Abe T (1991) Intravenous rt-PA in acute embolic stroke. In: Hacke W, Zoppo GJ del, Hirschberg M (eds) Thrombolytic therapy in acute stroke II. Springer, Berlin Heidelberg New York, pp 59-65
28. Zeumer H, Hacke W, Ringelstein EB (1983) Local intraarterial thrombolysis in vertebrobasilar themoboembolic disease. AJNR Am J Neuroradiol 4: 401-404
29. Zeumer H, Freitag HF, Grzyka U, Neunzig HP (1989) Local intra-arterial fibrinolysis in acute vertebrobasilar occlusion. Technical developments and recent results. Neuroradiology 31: 336-340
30. Zoppo GJ del, Ferbert A, Otis S, Brückmann H, Hacke W, Zyroff J, Harker LA, Zeumer H (1988) Local intra-arterial fibrinolytic therapy in acute carotid territory stroke: a pilot study. Stroke 19:307-313
31. Zoppo GJ del, Pessin MS, Mori E, Hacke W (1991) Thrombolytic intervention in acute thrombotic and embolic stroke. Semin Neurol 11:368-384